Last month, the findings from Quantify´s large RWE study using Danish RWD was presented at WCO- IOF-ESCEO
“This cohort patient study provides an invaluable blueprint to inform future treatment decision-making and support optimal use of romosozumab in clinical practice, both in Denmark and across Europe,” said Emmanuel Caeymaex, Executive Vice President, Immunology and U.S. Solutions at […]